{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:07:18Z","timestamp":1789420038010,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To quantitatively compare cerebral blood volume (CBV) in contrast-enhancing tumor areas and nonenhancing peritumoral fluid-attenuated inversion recovery (FLAIR) hyperintense regions between glioblastoma and central nervous system lymphoma (CNSL), and to assess the incremental diagnostic value of peritumoral CBV beyond enhancing tumor CBV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      The study included 34 patients with histopathologically confirmed glioblastoma (n=22) or CNSL (n=12) who underwent pretreatment magnetic resonance imaging, including FLAIR, dynamic susceptibility contrast perfusion imaging, and contrast-enhanced T1-weighted imaging. Automated regions of interest (ROIs) were defined for enhancement areas (EAs) and nonenhancing peritumoral FLAIR abnormalities (PFAs). Quantitative indices included the median CBV within EAs (CBV\n                      <jats:sub>EA<\/jats:sub>\n                      ) and the 95th percentile CBV within PFAs (CBV\n                      <jats:sub>PFA<\/jats:sub>\n                      ). Intergroup differences were assessed, and diagnostic performance was evaluated using univariate and multivariate logistic regression models incorporating CBV\n                      <jats:sub>EA<\/jats:sub>\n                      and CBV\n                      <jats:sub>PFA<\/jats:sub>\n                      , receiver operating characteristic (ROC) analysis, and likelihood ratio testing (LRT).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Both CBV\n                      <jats:sub>EA<\/jats:sub>\n                      and CBV\n                      <jats:sub>PFA<\/jats:sub>\n                      were significantly higher in the glioblastoma group than in the CNSL group [CBV\n                      <jats:sub>EA<\/jats:sub>\n                      : 4.90 (4.14-5.58) vs. 2.84 (2.04-3.21)\u00a0mL\/100\u00a0g,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.0001, CBV\n                      <jats:sub>PFA<\/jats:sub>\n                      : 5.67 (3.75-8.08) vs. 4.10 (3.00-5.23)\u00a0mL\/100\u00a0g;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.029]. CBV\n                      <jats:sub>EA<\/jats:sub>\n                      showed the highest discriminatory performance in univariate analysis, whereas CBV\n                      <jats:sub>PFA<\/jats:sub>\n                      demonstrated a more modest association with tumor type. Although the AUC of the combined model was not significantly different from that of the CBV\n                      <jats:sub>EA<\/jats:sub>\n                      model alone [CBV\n                      <jats:sub>EA<\/jats:sub>\n                      : 0.913 (0.816-1.000) vs. combined model: 0.932 (0.848-1.000),\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.602], the combined model showed a significant improvement in model fit according to LRT (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      =4.1,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.043).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Automated ROI-based analysis demonstrated significant differences in peritumoral CBV between glioblastoma and CNSL, and adding peritumoral CBV to the logistic regression model significantly improved overall model fit for differentiating between these entities beyond enhancing tumor CBV alone.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rct.0000000000001871","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T20:00:15Z","timestamp":1777060815000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Automated Quantitative Analysis of Enhancing and Peritumoral Cerebral Blood Volume for Differentiating Glioblastoma From Central Nervous System Lymphoma"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4167-1930","authenticated-orcid":false,"given":"Kazuhiro","family":"Murayama","sequence":"first","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Ohba","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Fujita Health University School of Medicine, Toyoake, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Maki","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunosuke","family":"Kumazawa","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomu","family":"Hanamatsu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Tamokami","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Nishikimi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9]]},"reference":[{"key":"R1-20260914","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"R2-20260914","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3171\/2011.2.JNS10998","article-title":"An extent of resection threshold for newly diagnosed glioblastomas","volume":"115","author":"Sanai","year":"2011","journal-title":"J Neurosurg"},{"key":"R3-20260914","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1016\/S1470-2045(17)30194-8","article-title":"European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncol"},{"key":"R4-20260914","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1016\/S1470-2045(15)00076-5","article-title":"Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology","volume":"16","author":"Hoang-Xuan","year":"2015","journal-title":"Lancet Oncol"},{"key":"R5-20260914","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1200\/JCO.2003.09.139","article-title":"Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience","volume":"21","author":"Ferreri","year":"2003","journal-title":"J Clin Oncol"},{"key":"R6-20260914","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1148\/radiol.14132740","article-title":"Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging","volume":"272","author":"Kickingereder","year":"2014","journal-title":"Radiology"},{"key":"R7-20260914","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1148\/radiol.14131895","article-title":"Atypical imaging features of primary central nervous system lymphoma that mimics glioblastoma: utility of intravoxel incoherent motion MR imaging","volume":"272","author":"Suh","year":"2014","journal-title":"Radiology"},{"key":"R8-20260914","doi-asserted-by":"crossref","first-page":"e0191341","DOI":"10.1371\/journal.pone.0191341","article-title":"Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach","volume":"13","author":"Neska-Matuszewska","year":"2018","journal-title":"PLoS ONE"},{"key":"R9-20260914","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2463\/mrms.mp.2016-0113","article-title":"Differentiating between central nervous system lymphoma and high-grade glioma using dynamic susceptibility contrast and dynamic contrast-enhanced MR imaging with histogram analysis","volume":"17","author":"Murayama","year":"2018","journal-title":"Magn Reson Med Sci"},{"key":"R10-20260914","doi-asserted-by":"crossref","first-page":"109900","DOI":"10.1016\/j.ejrad.2021.109900","article-title":"Advanced MRI assessment of non-enhancing peritumoral signal abnormality in brain lesions","volume":"143","author":"Martin-Noguerol","year":"2021","journal-title":"Eur J Radiol"},{"key":"R11-20260914","doi-asserted-by":"crossref","first-page":"e696","DOI":"10.1016\/j.wneu.2021.01.114","article-title":"Differentiating glioblastoma from primary central nervous system lymphoma: the value of shaping and nonenhancing peritumoral hyperintense gyral lesion on FLAIR imaging","volume":"149","author":"Wang","year":"2021","journal-title":"World Neurosurg"},{"key":"R12-20260914","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.acra.2023.08.008","article-title":"Distinguishing tumor cell infiltration and vasogenic edema in the peritumoral region of glioblastoma at the voxel level via conventional MRI sequences","volume":"31","author":"He","year":"2024","journal-title":"Acad Radiol"},{"key":"R13-20260914","doi-asserted-by":"crossref","first-page":"1347877","DOI":"10.3389\/fimmu.2024.1347877","article-title":"Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features","volume":"15","author":"Ballestin","year":"2024","journal-title":"Front Immunol"},{"key":"R14-20260914","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3892\/br.2023.1664","article-title":"Differentiation of glioblastoma and primary central nervous system lymphomas using multiparametric diffusion and perfusion magnetic resonance imaging","volume":"19","author":"Hung","year":"2023","journal-title":"Biomed Rep"},{"key":"R15-20260914","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neurad.2018.09.006","article-title":"Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T","volume":"46","author":"Askaner","year":"2019","journal-title":"J Neuroradiol"},{"key":"R16-20260914","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3390\/diagnostics15111324","article-title":"The significance of relative cerebral blood volume index in discriminating glial tumors from brain metastasis using perfusion magnetic resonance imaging","volume":"15","author":"Parlak","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"R17-20260914","doi-asserted-by":"crossref","first-page":"e890","DOI":"10.1016\/j.wneu.2018.07.291","article-title":"Perfusion computed tomography parameters are useful for differentiating glioblastoma, lymphoma, and metastasis","volume":"119","author":"Onishi","year":"2018","journal-title":"World Neurosurg"},{"key":"R18-20260914","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1109\/TIP.2008.2004611","article-title":"Localizing region-based active contours","volume":"17","author":"Lankton","year":"2008","journal-title":"IEEE Trans Image Process"},{"key":"R19-20260914","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1109\/83.902291","article-title":"Active contours without edges","volume":"10","author":"Chan","year":"2001","journal-title":"IEEE Trans Image Process"},{"key":"R20-20260914","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.3171\/2018.7.JNS18816","article-title":"Quantitative versus qualitative blood amount assessment as a predictor for shunt-dependent hydrocephalus following aneurysmal subarachnoid hemorrhage","volume":"131","author":"Garcia","year":"2019","journal-title":"J Neurosurg"},{"key":"R21-20260914","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jmri.70080","article-title":"Tumor habitats based on multiparametric MRI distinguish atypical glioblastoma from primary central nervous system lymphoma: imaging-pathologic correlation","volume":"63","author":"Sun","year":"2026","journal-title":"J Magn Reson Imaging"},{"key":"R22-20260914","first-page":"1989","article-title":"Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging","volume":"24","author":"Law","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"key":"R23-20260914","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.3390\/biomedicines11102731","article-title":"Peritumoral edema in gliomas: a review of mechanisms and management","volume":"11","author":"Ohmura","year":"2023","journal-title":"Biomedicines"},{"key":"R24-20260914","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12957-015-0496-7","article-title":"Peritumoral edema shown by MRI predicts poor clinical outcome in glioblastoma","volume":"13","author":"Wu","year":"2015","journal-title":"World J Surg Oncol"},{"key":"R25-20260914","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00062-024-01416-0","article-title":"Advanced diffusion MRI provides evidence for altered axonal microstructure and gradual peritumoral infiltration in GBM in comparison to brain metastases","volume":"34","author":"Wurtemberger","year":"2024","journal-title":"Clin Neuroradiol"},{"key":"R26-20260914","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.clineuro.2016.07.008","article-title":"Role of mass effect, tumor volume and peritumoral edema volume in the differential diagnosis of primary brain tumor and metastasis","volume":"148","author":"Baris","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"key":"R27-20260914","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00415-018-8737-7","article-title":"New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impact","volume":"265","author":"Blasel","year":"2018","journal-title":"J Neurol"},{"key":"R28-20260914","first-page":"1415","article-title":"Clinical value of vascular permeability estimates using dynamic susceptibility contrast MRI: improved diagnostic performance in distinguishing hypervascular primary CNS lymphoma from glioblastoma","volume":"39","author":"Lee","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"key":"R29-20260914","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1007\/s00330-023-09681-2","article-title":"Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling","volume":"33","author":"Yu","year":"2023","journal-title":"Eur Radiol"},{"key":"R30-20260914","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/neuonc\/nou142","article-title":"Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma","volume":"16","author":"LaViolette","year":"2014","journal-title":"Neuro Oncol"}],"container-title":["Journal of Computer Assisted Tomography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RCT.0000000000001871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:00:26Z","timestamp":1789419626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RCT.0000000000001871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rct.0000000000001871","relation":{},"ISSN":["1532-3145","0363-8715"],"issn-type":[{"value":"1532-3145","type":"electronic"},{"value":"0363-8715","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"2026-02-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}